Literature DB >> 2477396

Inability of AgNOR counts to differentiate between bronchial carcinoid tumours and small cell carcinoma of the bronchus.

E W Benbow, C J Cromie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477396      PMCID: PMC501809          DOI: 10.1136/jcp.42.9.1003

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  4 in total

1.  Atypical carcinoid of the lung. A distinct clinicopathologic entity.

Authors:  T H Grote; W R Macon; B Davis; F A Greco; D H Johnson
Journal:  Chest       Date:  1988-02       Impact factor: 9.410

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

3.  Application of the AgNOR method to cell imprints of lymphoid tissue.

Authors:  D A Boldy; J Crocker; J G Ayres
Journal:  J Pathol       Date:  1989-01       Impact factor: 7.996

4.  Nucleolar organiser regions in small cell carcinoma of the bronchus.

Authors:  J Crocker; J Ayres; J McGovern
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

  4 in total
  4 in total

Review 1.  Molecular biology and respiratory disease. 3. Evaluation of nucleolar organiser regions in pulmonary pathology.

Authors:  M J Egan; J Crocker
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

2.  Nucleolar organizer regions in normal, hyperplastic and neoplastic parathyroid glands.

Authors:  L L Boquist
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Prognostic value of nucleolar organizer regions in neuroendocrine tumours of the lung.

Authors:  J Böhm; V Kacic; P Gais; H W Präuer; H Höfler
Journal:  Histochemistry       Date:  1993-01

Review 4.  Nucleolar organiser regions in pathology.

Authors:  M J Egan; J Crocker
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.